Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Billionaire Portfolio: 7 Cheap Stocks Top Billionaires Are Accumulating

Page 1 of 2

In this piece, we discuss the Billionaire Portfolio: 7 Cheap Stocks Top Billionaires Are Accumulating.

The equity market continues to face a challenging backdrop amid rising geopolitical tensions, Reuters reported on March 27, 2026.

With the Middle East conflict now four weeks old, investors continue to pull their money out of the market as concerns surrounding inflation, growth, and consumer demand mount further. This week marked a fifth straight week of declines for Wall Street’s three main indexes.

According to Hargreaves Lansdown’s Matt Britzman, investor sentiment is not driven by price action alone. In fact, the lack of visible progress toward easing the conflict in the Middle East is weighing on investor confidence. Polar Capital’s Dan Boston expanded on that, noting that rising food and transportation costs are strengthening the case for higher inflation and hampering consumer sentiment.

On the other hand, Ocean Park Asset Management’s James St. Aubin cited the same factors, arguing that investor excitement around AI is fading. In the last quarter of 2025, the Nasdaq rose to record highs amid robust momentum in tech plays.

Thus, investor focus has shifted from growth themes like AI to macro risks tied to surging oil prices and rising bond yields. To make matters worse, market participants are now seeing a roughly 60% chance of a U.S. rate hike in 2026.

With this background in mind, let’s turn to our list of billionaire portfolio: 7 cheap stocks top billionaires are accumulating.

Photo by Joshua Hoehne on Unsplash

Methodology

For this article, we scanned the top billionaire holdings, looking for stocks trading at or below 15x forward earnings. We then ranked the list by the number of billionaires bullish on each stock as of Q4 2025, in ascending order. For billionaire sentiment, we relied on Insider Monkey’s billionaire database, which tracks over 100 billionaires as of Q4 2025.

Note: All data was extracted as of March 27, 2026.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).

7. The Cigna Group (NYSE:CI)

The Cigna Group (NYSE:CI) is among our picks in the list titled billionaire portfolio: 7 cheap stocks top billionaires are accumulating.

As of March 27, 2026, The Cigna Group (NYSE:CI) enjoys the confidence of roughly 90% of covering analysts who maintain bullish ratings on the stock. Based on the analyst consensus, the stock boasts an approximately 30% upside potential.

Similar optimism echoed at Bernstein, where analysts expect the stock’s valuation multiple to expand. Analyst confidence stems from drivers such as the PBM reform bill, the FTC settlement, The Cigna Group (NYSE:CI)’s previously announced PBM model changes, and its guidance tied to those changes.

With this investment thesis, Bernstein boosted its 2027-2030 EPS estimates, upgrading The Cigna Group (NYSE:CI) from “Market Perform” to “Outperform.” As of March 12, 2026, the firm maintains a $358 price target. For the current year, it kept its EPS estimates unchanged.

Recently, The Cigna Group (NYSE:CI) announced a leadership change, under which CEO David Cordani will retire, and Brian Evanko will succeed him. While the succession was inevitable, the timing of the move was criticized by Barclays analysts earlier this month, who cited the company’s early stage in its multi-year PBM transformation.

Around the same time, Piper Sandler’s analysts remained in favor of the PBM model changes, seeing less risky business dynamics following the change. Analysts further added that the company’s rebate-free pharmacy benefits model aligns with the 2025 Consolidated Appropriations Act and the FTC settlement. The firm cut its price target on The Cigna Group (NYSE:CI) from $374 to $370 and reiterated an “Overweight” rating.

The Cigna Group (NYSE:CI) operates as a global health services provider that offers pharmacy benefit management, specialty pharmacy, care delivery, and medical insurance solutions through its Evernorth Health Services and Cigna Healthcare segments worldwide.

Page 1 of 2

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee:  If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

No worries about auto-renewals! Our 30-Day Money-Back Guarantee applies whether you’re joining us for the first time or renewing your subscription a month later!